Skip to ContentSkip to Navigation
About us Practical matters How to find us dr. M. (Marco) de Bruyn

Publications

Vvax001, a Therapeutic Vaccine for Patients with HPV16-positive High-grade Cervical Intraepithelial Neoplasia: a Phase II Trial

128P - Whole blood transcriptomics identifies transcriptional patterns linked to outcomes in patients receiving immune checkpoint inhibitors

B cells critical for outcome in high grade serous ovarian carcinoma

Biomarker and transcriptomics profiles of serum selenium concentrations in patients with heart failure are associated with immunoregulatory processes

Correction to: Prediction of recurrence risk in endometrial cancer with multimodal deep learning (Nature Medicine, (2024), 10.1038/s41591-024-02993-w)

Genomic instability as a driver and suppressor of anti-tumor immunity

Immune predictors of response to immune checkpoint inhibitors in mismatch repair-deficient endometrial cancer

ImmunoPET provides a novel way to visualize the CD103+ tissue-resident memory T cell to predict the response of immune checkpoint inhibitors.

Neoadjuvant immune checkpoint blockade in women with mismatch repair deficient endometrial cancer: a phase I study

Prediction of recurrence risk in endometrial cancer with multimodal deep learning

Read more

Press/media

UMCG ontvangt subsidie voor onderzoek naar immuuntherapie bij baarmoederkanker

Onstekingsremmer als mogelijk medicijn bij agressieve kankers

Bij agressieve kankers kunnen mogelijk ontstekingsremmers helpen

Onstekingsremmer als mogelijk medicijn bij agressieve kankers

Read more